HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Shozo Sueda Selected Research

Spasm (Spasms)

11/2015Maximal acetylcholine dose of 200 μg into the left coronary artery as a spasm provocation test: comparison with 100 μg of acetylcholine.
9/2015Sequential spasm provocation tests might overcome a limitation of the standard spasm provocation tests.
7/2015Overview of the Acetylcholine Spasm Provocation Test.
1/2015One of six patients with non-ischemic heart disease exhibit provoked coronary spasms: non-ischemic heart disease associated with ischemia?
5/2010Coronary abnormal response has increased in Japanese patients: analysis of 17 years' spasm provocation tests in 2093 cases.
4/2008Recommendations for performing acetylcholine tests safely: STOP dangerous complications induced by acetylcholine tests (STOP DCIAT).
1/2007[Shock during spasm provocation tests with acetylcholine: four case reports].
11/2005Need for documentation of guidelines for coronary artery spasm: an investigation by questionnaire in Japan.
12/2004Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations.
7/2004Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Shozo Sueda Research Topics

Disease

15Spasm (Spasms)
11/2015 - 06/2002
3Chest Pain (Chest Pains)
02/2007 - 09/2002
2Heart Failure
09/2010 - 09/2008
2Shock
04/2008 - 01/2007
2Muscle Spasticity (Spastic)
02/2007 - 02/2003
2Pathologic Constriction (Stenosis)
01/2007 - 02/2003
2Coronary Vasospasm (Coronary Artery Vasospasm)
01/2007 - 10/2003
1Death (Near-Death Experience)
09/2010
1Aortic Aneurysm (Aneurysm, Aortic)
09/2010
1Myocardial Infarction
09/2010
1Stroke (Strokes)
09/2010
1Coronary Artery Disease (Coronary Atherosclerosis)
05/2010
1Apnea
09/2008
1Sleep Apnea Syndromes (Sleep Apnea)
09/2008
1Heart Diseases (Heart Disease)
09/2008
1Hypovolemia
04/2008
1Atrial Fibrillation
04/2008
1Cardiac Tamponade
04/2008
1Ventricular Tachycardia
04/2008
1Acute Coronary Syndrome
01/2007
1Insulin Resistance
09/2004
1Hypertension (High Blood Pressure)
09/2004
1Myocardial Ischemia (Ischemic Heart Diseases)
10/2003
1Angina Pectoris
07/2003
1Hyperemia
07/2003

Drug/Important Bio-Agent (IBA)

12Acetylcholine (Acetylcholine Chloride)FDA Link
11/2015 - 06/2002
7Ergonovine (Ergometrine)IBA
09/2015 - 09/2003
7Phenobarbital (Luminal)FDA Link
09/2015 - 06/2002
3Isosorbide Dinitrate (Isordil)FDA LinkGeneric
02/2007 - 12/2004
2Norepinephrine (Noradrenaline)FDA LinkGeneric
04/2008 - 01/2007
2CalciumIBA
02/2007 - 02/2003
1omega-Chloroacetophenone (Mace)IBA
09/2010
1SASIBA
09/2008
1cifenline (cibenzoline)IBA
04/2008
1Nicorandil (SG 75)IBA
02/2007
1iodofiltic acidIBA
02/2007
1Glucose (Dextrose)FDA LinkGeneric
09/2004
1troglitazone (Rezulin)FDA Link
09/2004
13-Iodobenzylguanidine (Iobenguane)IBA
09/2004
1Adrenergic Receptors (Adrenergic Receptor)IBA
10/2003
1Betaxolol (Kerlon)FDA LinkGeneric
10/2003
1Adenosine Triphosphate (ATP)IBA
09/2003
1Arginine (L-Arginine)FDA Link
07/2003
1omega-N-Methylarginine (NG Monomethyl L Arginine)IBA
07/2003
1cilostazol (Pletal)FDA LinkGeneric
07/2003
1ozagrelIBA
09/2002
1Thromboxane A2 (A2, Thromboxane)IBA
09/2002

Therapy/Procedure

1Stents
01/2007